Everpure trust proposes roughly $11.4M share sale
The proposed amount is listed at an aggregate market value of approximately $11,366,000, with a Rule 10b5-1 plan date of January 8, 2026.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Everpure, Inc. (P) is named as issuer in a notice that The Colgrove Family Charitable Remainder Trust U/A dated April 5, 2024 proposes to sell 100,000 common shares on approximately September 22, 2026, at an aggregate market value of approximately $11,366,000. The notice lists January 8, 2026 as the Rule 10b5-1 plan adoption or instruction date. It also reports that the trust sold 100,000 shares on September 21, 2026, for gross proceeds of $11,034,990, as part of the listed 10b5-1 sales. The relationship-to-issuer entries are Director and Officer; John A. Colgrove signed the notice.
Key Figures
Key Terms
Rule 10b5-1 regulatory
Aggregate Market Value financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What date is listed for the Everpure (P) Rule 10b5-1 plan?
What recent Everpure (P) sale by the Colgrove trust is reported?
AI-generated analysis. How Rhea-AI works. Not financial advice.